{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:54:05Z","timestamp":1794459245692,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>There is a continued perception that intravenous line (IV) placement is contraindicated in the arm ipsilateral to prior breast cancer surgery to avoid breast cancer\u2013related lymphedema (BCRL). The aim of this retrospective study was to determine the risk for development of BCRL in ipsilateral arm IV placement compared to contralateral arm IV placement to prior breast cancer surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a retrospective review, via our Integrated Clinical Systems and Epic Electronic Heath Record of IV placement for anesthesia and surgery in patients with a prior history of breast cancer surgery with or without axillary lymph node dissection. Complication rates were compared for IVs placed in the ipsilateral and contralateral arms. We identified 3724 patients undergoing 7896 IV placements between January 1, 2015, and May 5, 2018, with a prior history of breast cancer surgery via their index anesthesia and surgical procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The median time from breast cancer surgery to IV placement was 1.5 years (range, 1 day to 17.8 years). Of 2743 IVs placed in the arm contralateral to prior breast cancer surgery, 2 had a complication, corresponding to an incidence of 7.3 per 10,000 (95% confidence interval [CI], 0.9\u201326.3 per 10,000). Of 5153 IVs placed in the arm ipsilateral to prior breast cancer surgery, 2 IVs had a complication, for an incidence of 3.9 per 10,000 (95% CI, 0.5\u201314.0 per 10,000). The frequency of complications was not found to differ significantly between the groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .91), and the 95% CI for the risk difference (ipsilateral minus contralateral) was \u221223 to +8 complications per 10,000. The complication rate is similar when only the first IV placed following breast cancer surgery is considered (overall 5.4 per 10,000 [95% CI, 0.7\u201319.4] per 10,000; contralateral 7.0 [95% CI, 0.2\u201339.0] per 10,000, ipsilateral 4.4 [95% CI, 0.1\u201324.2] per 10,000;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 1.00; 95% CI for risk difference [ipsilateral minus contralateral], \u221241 to +22 per 10,000).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>We found very few complications in patients who had an IV placed for surgery following a previous breast cancer surgery and no complications in those patients with IV placement ipsilateral with axillary node dissection. Avoidance of IV placement in the arm ipsilateral to breast cancer surgery is not necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005597","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T15:00:26Z","timestamp":1622041226000},"page":"707-712","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients"],"prefix":"10.1213","volume":"133","author":[{"given":"Julian","family":"Naranjo","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica R.","family":"Portner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Jakub","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Cheville","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Nuttall","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"R1-20260529","first-page":"194","article-title":"The legacy of lymphedema: impact on nursing practice and vascular access.","volume":"29","author":"Larocque","year":"2019","journal-title":"Can Oncol Nurs J"},{"key":"R2-20260529","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","article-title":"Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study.","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R3-20260529","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment.","volume":"379","author":"Rockson","year":"2018","journal-title":"N Engl J Med"},{"key":"R4-20260529","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1200\/JCO.2015.61.5948","article-title":"Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer.","volume":"34","author":"Ferguson","year":"2016","journal-title":"J Clin Oncol"},{"key":"R5-20260529","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1016\/S1470-2045(16)30204-2","article-title":"Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis.","volume":"17","author":"Asdourian","year":"2016","journal-title":"Lancet Oncol"},{"key":"R6-20260529","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort.","volume":"28","author":"Kilbreath","year":"2016","journal-title":"Breast"},{"key":"R7-20260529","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jamcollsurg.2012.11.004","article-title":"Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery.","volume":"216","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Surg"},{"key":"R8-20260529","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1245\/s10434-012-2631-9","article-title":"Lifestyle risk factors associated with arm swelling among women with breast cancer.","volume":"20","author":"Showalter","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R9-20260529","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1245\/s10434-017-5964-6","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: part 2: preventive and therapeutic options.","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R10-20260529","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R11-20260529","article-title":"Overview of lymphedema for physicians and other clinicians: a review of fundamental concepts.","author":"Manrique","journal-title":"Mayo Clin Proc"},{"key":"R12-20260529","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"R13-20260529","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/gs.2017.11.04","article-title":"Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.","volume":"7","author":"Gillespie","year":"2018","journal-title":"Gland Surg"},{"key":"R14-20260529","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ans.12474","article-title":"Do medical procedures in the arm increase the risk of lymphoedema after axillary surgery? A review.","volume":"84","author":"Cheng","year":"2014","journal-title":"ANZ J Surg"},{"key":"R15-20260529","first-page":"242","article-title":"Lymphedema: separating fact from fiction.","volume":"26","author":"McLaughlin","year":"2012","journal-title":"Oncology (Williston Park)"},{"key":"R16-20260529","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.3747\/co.25.3911","article-title":"Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey.","volume":"25","author":"LeVasseur","year":"2018","journal-title":"Curr Oncol"},{"key":"R17-20260529","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.12968\/bjon.2020.29.14.S32","article-title":"Time to rethink vascular access in patients with breast cancer.","volume":"29","author":"McDiarmid","year":"2020","journal-title":"Br J Nurs"},{"key":"R18-20260529","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002060-199202000-00004","article-title":"Lymphedema 30 years after radical mastectomy.","volume":"71","author":"Brennan","year":"1992","journal-title":"Am J Phys Med Rehabil"},{"key":"R19-20260529","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0885-3924(92)90122-X","article-title":"Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment.","volume":"7","author":"Brennan","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"R20-20260529","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/qjmed\/hci053","article-title":"Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study.","volume":"98","author":"Clark","year":"2005","journal-title":"QJM"},{"key":"R21-20260529","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02303628","article-title":"Elective hand surgery in the breast cancer patient with prior ipsilateral axillary dissection.","volume":"2","author":"Dawson","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"R22-20260529","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-015-3500-6","article-title":"Impact of carpal tunnel syndrome surgery on women with breast cancer-related lymphedema.","volume":"152","author":"Gunnoo","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R23-20260529","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.3928\/01477447-20150504-52","article-title":"Elective hand surgery after axillary lymph node dissection for cancer.","volume":"38","author":"Lee","year":"2015","journal-title":"Orthopedics"},{"key":"R24-20260529","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/SAP.0000000000000986","article-title":"De novo upper extremity lymphedema after elective hand surgery in breast cancer survivors.","volume":"79","author":"Baltzer","year":"2017","journal-title":"Ann Plast Surg"},{"key":"R25-20260529","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.amjmed.2019.08.054","article-title":"Peripheral vein thrombophlebitis in the upper extremity: a systematic review of a frequent and important problem.","volume":"133","author":"Heng","year":"2020","journal-title":"Am J Med"},{"key":"R26-20260529","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1129729819877323","article-title":"The incidence and risk of infusion phlebitis with peripheral intravenous catheters: a meta-analysis.","volume":"21","author":"Lv","year":"2020","journal-title":"J Vasc Access"},{"key":"R27-20260529","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:52Z","timestamp":1786112752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005597","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740186843.793589401","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740186843.793588540","asserted-by":"object"}]},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}